FDA NDC Directory · JSON-LD · Markdown

Xerava

NDC 71773-050 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nameeravacycline
Labeler / ManufacturerTetraphase Pharmaceuticals, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA211109
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsERAVACYCLINE DIHYDROCHLORIDE (50 mg/1)
Marketing started20180910
Package count2

External sources

Source: openFDA. Public-domain (CC0).